Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus.

Iannacone M, Moseman EA, Tonti E, Bosurgi L, Junt T, Henrickson SE, Whelan SP, Guidotti LG, von Andrian UH.

Nature. 2010 Jun 24;465(7301):1079-83. doi: 10.1038/nature09118.

2.

Chapter 2: Kill the bacteria...and also their messengers?

Munford R, Lu M, Varley A.

Adv Immunol. 2009;103:29-48. doi: 10.1016/S0065-2776(09)03002-8. Review.

3.

Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection.

Lu M, Varley AW, Ohta S, Hardwick J, Munford RS.

Cell Host Microbe. 2008 Sep 11;4(3):293-302. doi: 10.1016/j.chom.2008.06.009.

4.

Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Munford RS.

Infect Immun. 2008 Feb;76(2):454-65. Epub 2007 Dec 17. Review. No abstract available.

5.

Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells.

Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, Boes M, Fink K, Henrickson SE, Shayakhmetov DM, Di Paolo NC, van Rooijen N, Mempel TR, Whelan SP, von Andrian UH.

Nature. 2007 Nov 1;450(7166):110-4. Epub 2007 Oct 14.

PMID:
17934446
6.

Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.

Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, Enkhbayar P, Matsushima N, Lee H, Yoo OJ, Lee JO.

Cell. 2007 Sep 7;130(5):906-17.

7.

A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen.

Shao B, Lu M, Katz SC, Varley AW, Hardwick J, Rogers TE, Ojogun N, Rockey DC, Dematteo RP, Munford RS.

J Biol Chem. 2007 May 4;282(18):13726-35. Epub 2007 Feb 24.

8.

Endotoxin-binding proteins modulate the susceptibility of bacterial endotoxin to deacylation by acyloxyacyl hydrolase.

Gioannini TL, Teghanemt A, Zhang D, Prohinar P, Levis EN, Munford RS, Weiss JP.

J Biol Chem. 2007 Mar 16;282(11):7877-84. Epub 2007 Jan 16.

9.

Induction of long-term lipopolysaccharide tolerance by an agonistic monoclonal antibody to the toll-like receptor 4/MD-2 complex.

Ohta S, Bahrun U, Shimazu R, Matsushita H, Fukudome K, Kimoto M.

Clin Vaccine Immunol. 2006 Oct;13(10):1131-6.

10.

Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells.

Qi H, Egen JG, Huang AY, Germain RN.

Science. 2006 Jun 16;312(5780):1672-6.

11.

R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.

Huber M, Kalis C, Keck S, Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Beutler B, Galanos C, Freudenberg MA.

Eur J Immunol. 2006 Mar;36(3):701-11.

12.

Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria.

Lu M, Zhang M, Takashima A, Weiss J, Apicella MA, Li XH, Yuan D, Munford RS.

Nat Immunol. 2005 Oct;6(10):989-94. Epub 2005 Sep 11.

PMID:
16155573
13.

Dendritic-cell trafficking to lymph nodes through lymphatic vessels.

Randolph GJ, Angeli V, Swartz MA.

Nat Rev Immunol. 2005 Aug;5(8):617-28. Review.

PMID:
16056255
14.

Detoxifying endotoxin: time, place and person.

Munford RS.

J Endotoxin Res. 2005;11(2):69-84. Review.

PMID:
15949133
15.

Identification of acyloxyacyl hydrolase, a lipopolysaccharide-detoxifying enzyme, in the murine urinary tract.

Feulner JA, Lu M, Shelton JM, Zhang M, Richardson JA, Munford RS.

Infect Immun. 2004 Jun;72(6):3171-8.

16.

Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo.

Rotta G, Edwards EW, Sangaletti S, Bennett C, Ronzoni S, Colombo MP, Steinman RM, Randolph GJ, Rescigno M.

J Exp Med. 2003 Oct 20;198(8):1253-63.

17.

Stimulus-dependent deacylation of bacterial lipopolysaccharide by dendritic cells.

Lu M, Zhang M, Kitchens RL, Fosmire S, Takashima A, Munford RS.

J Exp Med. 2003 Jun 16;197(12):1745-54.

19.

Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo.

Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA.

Immunity. 1999 Dec;11(6):753-61.

20.

Lymph of patients with a systemic inflammatory response syndrome inhibits lipopolysaccharide-induced cytokine production.

Lemaire LC, van Lanschot JJ, van der Poll T, Buurman WA, van Deventer SJ, Gouma DJ.

J Infect Dis. 1998 Sep;178(3):883-6.

PMID:
9728565

Supplemental Content

Support Center